Cormorant Asset Management, LP CRNX Holdings History
Cormorant Asset Management, LP's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Cormorant Asset Management, LP held 600,000.00 shares of Crinetics Pharmaceuticals Inc(CRNX), totaling $20.12 Mil. This investment constitutes 1.51% of their stock portfolio, and Cormorant Asset Management, LP now holds 0.64% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2023Q3. And since then Cormorant Asset Management, LP has made 3 purchases of CRNX, at an average price of $24.76, for a total of 1.35 Mil shares. In addition, there have been 3 sales at an average price of $44.58 for 750,000.00 shares. Based on historical transaction data and CRNX's current price of $31.11, Cormorant Asset Management, LP's estimated gain on his CRNX holdings is $18.68 Mil, reflecting a 55.89% gain to date.
Cormorant Asset Management, LP CRNX ($31.11) Holding Chart
Cormorant Asset Management, LP CRNX ($31.11) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
